ERS statement on protracted bacterial bronchitis in children

Ahmad Kantar, Anne B. Chang, Mike D. Shields, Julie M. Marchant, Keith Grimwood, Jonathan Grigg, Kostas N. Priftis, Renato Cutrera, Fabio Midulla, Paul L. P. Brand, Mark L. Everard

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This European Respiratory Society statement provides a comprehensive overview on protracted bacterial bronchitis (PBB) in children. A task force of experts, consisting of clinicians from Europe and Australia who manage children with PBB determined the overall scope of this statement through consensus. Systematic reviews addressing key questions were undertaken, diagrams in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement constructed and findings of relevant studies summarised. The final content of this statement was agreed upon by all members.

The current knowledge regarding PBB is presented, including the definition, microbiology data, known pathobiology, bronchoalveolar lavage findings and treatment strategies to manage these children. Evidence for the definition of PBB was sought specifically and presented. In addition, the task force identified several major clinical areas in PBB requiring further research, including collecting more prospective data to better identify the disease burden within the community, determining its natural history, a better understanding of the underlying disease mechanisms and how to optimise its treatment, with a particular requirement for randomised controlled trials to be conducted in primary care.

Original languageEnglish
Article number1602139
Number of pages18
JournalThe European Respiratory Journal
Volume50
Issue number2
DOIs
Publication statusPublished - 1 Aug 2017

Cite this

Kantar, A., Chang, A. B., Shields, M. D., Marchant, J. M., Grimwood, K., Grigg, J., ... Everard, M. L. (2017). ERS statement on protracted bacterial bronchitis in children. The European Respiratory Journal, 50(2), [1602139]. https://doi.org/10.1183/13993003.02139-2016
Kantar, Ahmad ; Chang, Anne B. ; Shields, Mike D. ; Marchant, Julie M. ; Grimwood, Keith ; Grigg, Jonathan ; Priftis, Kostas N. ; Cutrera, Renato ; Midulla, Fabio ; Brand, Paul L. P. ; Everard, Mark L. / ERS statement on protracted bacterial bronchitis in children. In: The European Respiratory Journal. 2017 ; Vol. 50, No. 2.
@article{c6b555a77e1c492d9932e674582c722c,
title = "ERS statement on protracted bacterial bronchitis in children",
abstract = "This European Respiratory Society statement provides a comprehensive overview on protracted bacterial bronchitis (PBB) in children. A task force of experts, consisting of clinicians from Europe and Australia who manage children with PBB determined the overall scope of this statement through consensus. Systematic reviews addressing key questions were undertaken, diagrams in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement constructed and findings of relevant studies summarised. The final content of this statement was agreed upon by all members.The current knowledge regarding PBB is presented, including the definition, microbiology data, known pathobiology, bronchoalveolar lavage findings and treatment strategies to manage these children. Evidence for the definition of PBB was sought specifically and presented. In addition, the task force identified several major clinical areas in PBB requiring further research, including collecting more prospective data to better identify the disease burden within the community, determining its natural history, a better understanding of the underlying disease mechanisms and how to optimise its treatment, with a particular requirement for randomised controlled trials to be conducted in primary care.",
keywords = "CHRONIC WET COUGH, SUPPURATIVE LUNG-DISEASE, RANDOMIZED CONTROLLED-TRIAL, LONG-TERM AZITHROMYCIN, BRONCHOALVEOLAR LAVAGE, BRONCHOSCOPIC FINDINGS, MORAXELLA-CATARRHALIS, INDIGENOUS CHILDREN, PRODUCTIVE COUGH, PERSISTENT COUGH",
author = "Ahmad Kantar and Chang, {Anne B.} and Shields, {Mike D.} and Marchant, {Julie M.} and Keith Grimwood and Jonathan Grigg and Priftis, {Kostas N.} and Renato Cutrera and Fabio Midulla and Brand, {Paul L. P.} and Everard, {Mark L.}",
year = "2017",
month = "8",
day = "1",
doi = "10.1183/13993003.02139-2016",
language = "English",
volume = "50",
journal = "The European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Soc Journals Ltd",
number = "2",

}

Kantar, A, Chang, AB, Shields, MD, Marchant, JM, Grimwood, K, Grigg, J, Priftis, KN, Cutrera, R, Midulla, F, Brand, PLP & Everard, ML 2017, 'ERS statement on protracted bacterial bronchitis in children' The European Respiratory Journal, vol. 50, no. 2, 1602139. https://doi.org/10.1183/13993003.02139-2016

ERS statement on protracted bacterial bronchitis in children. / Kantar, Ahmad; Chang, Anne B.; Shields, Mike D.; Marchant, Julie M.; Grimwood, Keith; Grigg, Jonathan; Priftis, Kostas N.; Cutrera, Renato; Midulla, Fabio; Brand, Paul L. P.; Everard, Mark L.

In: The European Respiratory Journal, Vol. 50, No. 2, 1602139, 01.08.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - ERS statement on protracted bacterial bronchitis in children

AU - Kantar, Ahmad

AU - Chang, Anne B.

AU - Shields, Mike D.

AU - Marchant, Julie M.

AU - Grimwood, Keith

AU - Grigg, Jonathan

AU - Priftis, Kostas N.

AU - Cutrera, Renato

AU - Midulla, Fabio

AU - Brand, Paul L. P.

AU - Everard, Mark L.

PY - 2017/8/1

Y1 - 2017/8/1

N2 - This European Respiratory Society statement provides a comprehensive overview on protracted bacterial bronchitis (PBB) in children. A task force of experts, consisting of clinicians from Europe and Australia who manage children with PBB determined the overall scope of this statement through consensus. Systematic reviews addressing key questions were undertaken, diagrams in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement constructed and findings of relevant studies summarised. The final content of this statement was agreed upon by all members.The current knowledge regarding PBB is presented, including the definition, microbiology data, known pathobiology, bronchoalveolar lavage findings and treatment strategies to manage these children. Evidence for the definition of PBB was sought specifically and presented. In addition, the task force identified several major clinical areas in PBB requiring further research, including collecting more prospective data to better identify the disease burden within the community, determining its natural history, a better understanding of the underlying disease mechanisms and how to optimise its treatment, with a particular requirement for randomised controlled trials to be conducted in primary care.

AB - This European Respiratory Society statement provides a comprehensive overview on protracted bacterial bronchitis (PBB) in children. A task force of experts, consisting of clinicians from Europe and Australia who manage children with PBB determined the overall scope of this statement through consensus. Systematic reviews addressing key questions were undertaken, diagrams in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement constructed and findings of relevant studies summarised. The final content of this statement was agreed upon by all members.The current knowledge regarding PBB is presented, including the definition, microbiology data, known pathobiology, bronchoalveolar lavage findings and treatment strategies to manage these children. Evidence for the definition of PBB was sought specifically and presented. In addition, the task force identified several major clinical areas in PBB requiring further research, including collecting more prospective data to better identify the disease burden within the community, determining its natural history, a better understanding of the underlying disease mechanisms and how to optimise its treatment, with a particular requirement for randomised controlled trials to be conducted in primary care.

KW - CHRONIC WET COUGH

KW - SUPPURATIVE LUNG-DISEASE

KW - RANDOMIZED CONTROLLED-TRIAL

KW - LONG-TERM AZITHROMYCIN

KW - BRONCHOALVEOLAR LAVAGE

KW - BRONCHOSCOPIC FINDINGS

KW - MORAXELLA-CATARRHALIS

KW - INDIGENOUS CHILDREN

KW - PRODUCTIVE COUGH

KW - PERSISTENT COUGH

U2 - 10.1183/13993003.02139-2016

DO - 10.1183/13993003.02139-2016

M3 - Article

VL - 50

JO - The European Respiratory Journal

JF - The European Respiratory Journal

SN - 0903-1936

IS - 2

M1 - 1602139

ER -

Kantar A, Chang AB, Shields MD, Marchant JM, Grimwood K, Grigg J et al. ERS statement on protracted bacterial bronchitis in children. The European Respiratory Journal. 2017 Aug 1;50(2). 1602139. https://doi.org/10.1183/13993003.02139-2016